• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AAV 载体介导的体内重编程为多能性。

AAVvector-mediated in vivo reprogramming into pluripotency.

机构信息

Virus-Host Interaction Group, Department of Infectious Diseases/Virology, Heidelberg University Hospital, Cluster of Excellence CellNetworks, Heidelberg, 69120, Germany.

BioQuant, University of Heidelberg, Heidelberg, 69120, Germany.

出版信息

Nat Commun. 2018 Jul 9;9(1):2651. doi: 10.1038/s41467-018-05059-x.

DOI:10.1038/s41467-018-05059-x
PMID:29985406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037684/
Abstract

In vivo reprogramming of somatic cells into induced pluripotent stem cells (iPSC) holds vast potential for basic research and regenerative medicine. However, it remains hampered by a need for vectors to express reprogramming factors (Oct-3/4, Klf4, Sox2, c-Myc; OKSM) in selected organs. Here, we report OKSM delivery vectors based on pseudotyped Adeno-associated virus (AAV). Using the AAV-DJ capsid, we could robustly reprogram mouse embryonic fibroblasts with low vector doses. Swapping to AAV8 permitted to efficiently reprogram somatic cells in adult mice by intravenous vector delivery, evidenced by hepatic or extra-hepatic teratomas and iPSC in the blood. Notably, we accomplished full in vivo reprogramming without c-Myc. Most iPSC generated in vitro or in vivo showed transcriptionally silent, intronic or intergenic vector integration, likely reflecting the increased host genome accessibility during reprogramming. Our approach crucially advances in vivo reprogramming technology, and concurrently facilitates investigations into the mechanisms and consequences of AAV persistence.

摘要

体细胞重编程为诱导多能干细胞(iPSC)在基础研究和再生医学中有巨大的潜力。然而,它仍然受到需要载体在选定的器官中表达重编程因子(Oct-3/4、Klf4、Sox2、c-Myc;OKSM)的限制。在这里,我们报告了基于假型腺相关病毒(AAV)的 OKSM 传递载体。使用 AAV-DJ 衣壳,我们可以用低剂量的载体有效地重编程小鼠胚胎成纤维细胞。通过静脉内载体递送,将 AAV8 替换为 AAV8 可以有效地在成年小鼠中重编程体细胞,这可以通过肝内或肝外畸胎瘤和血液中的 iPSC 来证明。值得注意的是,我们在没有 c-Myc 的情况下完成了完全的体内重编程。大多数在体外或体内生成的 iPSC 显示转录沉默、内含子或基因间载体整合,这可能反映了在重编程过程中宿主基因组的可及性增加。我们的方法极大地推进了体内重编程技术的发展,同时也促进了对 AAV 持续性的机制和后果的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/620ad8e729b8/41467_2018_5059_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/71ac00eaf62a/41467_2018_5059_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/bf8770dbf0fc/41467_2018_5059_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/af00cb0fec37/41467_2018_5059_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/620ad8e729b8/41467_2018_5059_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/71ac00eaf62a/41467_2018_5059_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/bf8770dbf0fc/41467_2018_5059_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/af00cb0fec37/41467_2018_5059_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3821/6037684/620ad8e729b8/41467_2018_5059_Fig4_HTML.jpg

相似文献

1
AAVvector-mediated in vivo reprogramming into pluripotency.AAV 载体介导的体内重编程为多能性。
Nat Commun. 2018 Jul 9;9(1):2651. doi: 10.1038/s41467-018-05059-x.
2
A Versatile In Vivo System to Study Myc in Cell Reprogramming.一种用于研究 Myc 在细胞重编程中的多功能体内系统。
Methods Mol Biol. 2021;2318:267-279. doi: 10.1007/978-1-0716-1476-1_14.
3
Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.通过重组腺相关病毒介导的转导重编程的诱导多能干细胞克隆含有整合的载体序列。
J Virol. 2012 Apr;86(8):4463-7. doi: 10.1128/JVI.06302-11. Epub 2012 Feb 1.
4
Induced pluripotent reprogramming from promiscuous human stemness related factors.诱导多能重编程从杂乱无章的人类干性相关因子。
Clin Transl Sci. 2009 Apr;2(2):118-26. doi: 10.1111/j.1752-8062.2009.00091.x.
5
MicroRNA-Mediated Reprogramming of Somatic Cells into Induced Pluripotent Stem Cells.微小RNA介导的体细胞重编程为诱导多能干细胞
Methods Mol Biol. 2015;1330:29-36. doi: 10.1007/978-1-4939-2848-4_3.
6
Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.从成年犬成纤维细胞生成诱导多能干细胞(iPSC)
Methods Mol Biol. 2015;1330:69-78. doi: 10.1007/978-1-4939-2848-4_7.
7
Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.重编程方法不影响人类诱导多能干细胞的基因表达谱。
Int J Mol Sci. 2017 Jan 20;18(1):206. doi: 10.3390/ijms18010206.
8
Nuclear reprogramming with a non-integrating human RNA virus.利用非整合型人类RNA病毒进行核重编程。
Stem Cell Res Ther. 2015 Mar 26;6(1):48. doi: 10.1186/s13287-015-0035-z.
9
Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.操纵 KLF4 表达可产生在重编程的连续阶段暂停的 iPSCs。
Stem Cell Reports. 2014 Nov 11;3(5):915-29. doi: 10.1016/j.stemcr.2014.08.014. Epub 2014 Oct 2.
10
Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.简要报告:联合化学处理可实现 Oct4 诱导的小鼠胚胎成纤维细胞重编程。
Stem Cells. 2011 Mar;29(3):549-53. doi: 10.1002/stem.594.

引用本文的文献

1
Development of a Lentiviral Reporter System for In Vitro Reprogramming of Astrocytes to Neuronal Precursors.用于体外将星形胶质细胞重编程为神经前体细胞的慢病毒报告系统的开发
Biology (Basel). 2025 Jul 5;14(7):817. doi: 10.3390/biology14070817.
2
Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research.芯片上的衰老:利用微流控技术在衰老与年轻化研究中的潜力
Adv Healthc Mater. 2025 Aug;14(20):e2500217. doi: 10.1002/adhm.202500217. Epub 2025 Jun 12.
3
Current advances and future prospects of cell reprogramming in progeroid syndromes.

本文引用的文献

1
In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases.体内瞬时和部分细胞重编程为多能性作为神经退行性疾病的治疗工具。
Mol Neurobiol. 2018 Aug;55(8):6850-6862. doi: 10.1007/s12035-018-0888-0. Epub 2018 Jan 20.
2
In vivo reprogramming for tissue regeneration and organismal rejuvenation.体内重编程用于组织再生和机体 rejuvenation。
Curr Opin Genet Dev. 2017 Oct;46:132-140. doi: 10.1016/j.gde.2017.07.008. Epub 2017 Aug 2.
3
Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.
早衰综合征中细胞重编程的当前进展与未来前景
Front Cell Dev Biol. 2025 Feb 19;13:1546423. doi: 10.3389/fcell.2025.1546423. eCollection 2025.
4
Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy.腺相关病毒载体:基因治疗的原理、实践与前景
Viruses. 2025 Feb 9;17(2):239. doi: 10.3390/v17020239.
5
Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience.s-KL治疗对野生型小鼠的长期影响:延长寿命、提升身体健康和增强神经恢复力。
Mol Ther. 2025 Apr 2;33(4):1449-1465. doi: 10.1016/j.ymthe.2025.02.030. Epub 2025 Feb 22.
6
Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture.鸟类中的诱导多能干细胞:科学与农业面临的机遇与挑战
Vet Sci. 2024 Dec 19;11(12):666. doi: 10.3390/vetsci11120666.
7
STEMIN and YAP5SA, the future of heart repair?STEMIN 和 YAP5SA,心脏修复的未来?
Exp Biol Med (Maywood). 2024 Oct 31;249:10246. doi: 10.3389/ebm.2024.10246. eCollection 2024.
8
The Progress and Promise of Lineage Reprogramming Strategies for Liver Regeneration.谱系重编程策略在肝脏再生中的进展和前景。
Cell Mol Gastroenterol Hepatol. 2024;18(6):101395. doi: 10.1016/j.jcmgh.2024.101395. Epub 2024 Aug 30.
9
AAV-mediated gene therapy restores natural fertility and improves physical function in the Lhcgr-deficient mouse model of Leydig cell failure.腺相关病毒介导的基因治疗恢复了 Lhcgr 缺陷型莱迪希细胞功能衰竭小鼠模型的自然生育能力和改善了其身体机能。
Cell Prolif. 2024 Sep;57(9):e13680. doi: 10.1111/cpr.13680. Epub 2024 May 30.
10
A Youthful Touch: Reversal of Aging Hallmarks by Cell Reprogramming.青春之触:通过细胞重编程逆转衰老特征
Cells Tissues Organs. 2024;213(6):538-550. doi: 10.1159/000539415. Epub 2024 May 20.
鉴定野生型 AAV2 基因组 3'非翻译区中的肝脏特异性增强子-启动子活性。
Nat Genet. 2017 Aug;49(8):1267-1273. doi: 10.1038/ng.3893. Epub 2017 Jun 19.
4
Comparative Analysis of Non-viral Transfection Methods in Mouse Embryonic Fibroblast Cells.小鼠胚胎成纤维细胞中非病毒转染方法的比较分析
J Biomol Tech. 2017 Jul;28(2):67-74. doi: 10.7171/jbt.17-2802-003. Epub 2017 Apr 29.
5
Transient transcription factor (OSKM) expression is key towards clinical translation of cell reprogramming.瞬时转录因子(OSKM)的表达是细胞重编程向临床转化的关键。
EMBO Mol Med. 2017 Jun;9(6):733-736. doi: 10.15252/emmm.201707650.
6
GENE-IS: Time-Efficient and Accurate Analysis of Viral Integration Events in Large-Scale Gene Therapy Data.GENE-IS:对大规模基因治疗数据中的病毒整合事件进行高效准确的分析。
Mol Ther Nucleic Acids. 2017 Mar 17;6:133-139. doi: 10.1016/j.omtn.2016.12.001. Epub 2016 Dec 10.
7
Unveiling the Role of Senescence-Induced Cellular Plasticity.揭示衰老诱导的细胞可塑性的作用。
Cell Stem Cell. 2017 Mar 2;20(3):293-294. doi: 10.1016/j.stem.2017.02.001.
8
A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear.一种合成腺相关病毒载体可实现向哺乳动物内耳的安全高效基因转移。
Nat Biotechnol. 2017 Mar;35(3):280-284. doi: 10.1038/nbt.3781. Epub 2017 Feb 6.
9
Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis.体内重编程和肿瘤发生早期阶段常见的端粒变化。
Stem Cell Reports. 2017 Feb 14;8(2):460-475. doi: 10.1016/j.stemcr.2017.01.001. Epub 2017 Feb 2.
10
Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle.损伤诱导的衰老使骨骼肌体内重编程成为可能。
Cell Stem Cell. 2017 Mar 2;20(3):407-414.e4. doi: 10.1016/j.stem.2016.11.020. Epub 2016 Dec 22.